Deepcell
Founded
2017
2017
Patents
1
1
Technologies
AI Companies (Drug Discovery)Spun out of Stanford University in 2017, the company has created unique, microfluidics-based technology that uses continuously learning AI to classify cells based on detailed visual features and sort them without inherent bias.
Deepcell offers an AI-powered imaging and microfluidics platform that identifies and isolates viable cells based on morphological distinctions for use in translational research, diagnostic testing, and therapeutics.
Become a Member to view additional information about this company